928 related articles for article (PubMed ID: 25754617)
21. Niacin for primary and secondary prevention of cardiovascular events.
Schandelmaier S; Briel M; Saccilotto R; Olu KK; Arpagaus A; Hemkens LG; Nordmann AJ
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009744. PubMed ID: 28616955
[TBL] [Abstract][Full Text] [Related]
22. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Martin N; Bridges C; Brainard JS; Wang X; Brown TJ; Hanson S; Jimoh OF; Ajabnoor SM; Deane KH; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012345. PubMed ID: 30484282
[TBL] [Abstract][Full Text] [Related]
23. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
[TBL] [Abstract][Full Text] [Related]
24. Statins for the primary prevention of cardiovascular disease.
Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
[TBL] [Abstract][Full Text] [Related]
25. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
26. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Martin N; Bridges C; Brainard JS; Wang X; Brown TJ; Hanson S; Jimoh OF; Ajabnoor SM; Deane KH; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012345. PubMed ID: 30019767
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010315. PubMed ID: 32905623
[TBL] [Abstract][Full Text] [Related]
28. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
[TBL] [Abstract][Full Text] [Related]
29. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
30. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
[TBL] [Abstract][Full Text] [Related]
31. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease.
Dyakova M; Shantikumar S; Colquitt JL; Drew CM; Sime M; MacIver J; Wright N; Clarke A; Rees K
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010411. PubMed ID: 26824223
[TBL] [Abstract][Full Text] [Related]
32. Reduction in saturated fat intake for cardiovascular disease.
Hooper L; Martin N; Jimoh OF; Kirk C; Foster E; Abdelhamid AS
Cochrane Database Syst Rev; 2020 May; 5(5):CD011737. PubMed ID: 32428300
[TBL] [Abstract][Full Text] [Related]
33. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
34. Reduction in saturated fat intake for cardiovascular disease.
Hooper L; Martin N; Jimoh OF; Kirk C; Foster E; Abdelhamid AS
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD011737. PubMed ID: 32827219
[TBL] [Abstract][Full Text] [Related]
35. Treatment of distal deep vein thrombosis.
Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
37. Blood pressure targets in adults with hypertension.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584
[TBL] [Abstract][Full Text] [Related]
38. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.
Bahiru E; de Cates AN; Farr MR; Jarvis MC; Palla M; Rees K; Ebrahim S; Huffman MD
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD009868. PubMed ID: 28263370
[TBL] [Abstract][Full Text] [Related]
39. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004080. PubMed ID: 31329285
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]